Stage IE nonHodgkin's lymphoma of the testis: a need for a brief aggressive chemotherapy.
Primary nonHodgkin's lymphoma of the testis is a localized disease in 50 per cent of the cases. Clinical records and pathological material from 9 stage IE cancer patients treated at our institutions were reviewed. All but 1 patient had B cell type lymphomas of intermediate (6) or high (3) grade according to the Working Formulation. Mean survival was 49 months and actuarial survival was 74 per cent at 5 years. Chemotherapy differed with time and frequently was associated with subdiaphragmatic involved field and prophylactic contralateral testis radiotherapy. In view of the good prognosis of patients receiving doxorubicin-based chemotherapy and recent reports on low stage nonHodgkin's lymphoma we recommend an aggressive brief therapy for stage IE lymphoma of the testis after orchiectomy.
Roche
H
H
Service d'oncolozie medicale, Centre Claudius Regaud, Toulouse, France.
Suc
E
E
Pons
A
A
Woodman
F
F
Huguet-Rigal
F
F
Caveriviere
P
P
Carton
M
M
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D011867:Radioisotope Teletherapy; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000401:mortality
D003037:Cobalt Radioisotopes; D004317:Doxorubicin